Stomach dose-volume parameters and clinical factors predict acute toxicity in pancreatic cancer chemoradiotherapy

Stomach dose-volume parameters and clinical factors predict acute toxicity in pancreatic cancer chemoradiotherapy

Gastrointestinal (GI) toxicity impedes dose escalation and likelihood of cure in chemoradiotherapy (CRT) for hepatobiliary malignancies. The risk of toxicity can depend on clinical and radiotherapy (RT) dose-volume metrics. We aimed to identify predictive factors using data from two prospective phas...

Volledige beschrijving

Bibliografische gegevens
Hoofdauteurs:	Holyoake, D, Partridge, M, Hurt, C, Mukherjee, S, Hawkins, M
Formaat:	Conference item
Gepubliceerd in:	Elsevier 2017

Gelijkaardige items

Stomach dose-volume predicts acute gastrointestinal toxicity in chemoradiotherapy for locally advanced pancreatic cancer
door: Holyoake, DLP, et al.
Gepubliceerd in: (2018)

Dosimetric parameters predict toxicity in chemoradiotherapy with nelfinavir for pancreatic cancer
door: Holyoake, D, et al.
Gepubliceerd in: (2016)

Modelling duodenum radiotherapy toxicity using cohort dose-volume-histogram data
door: Holyoake, D, et al.
Gepubliceerd in: (2017)

Systematic review and meta-analysis of small bowel dose–volume and acute toxicity in conventionally-fractionated rectal cancer radiotherapy
door: Holyoake, D, et al.
Gepubliceerd in: (2019)

Meta-analysis of toxicity and small-bowel radiotherapy dose-volume: “omnibus consequentia”
door: Holyoake, D, et al.
Gepubliceerd in: (2018)

Can protons reduce bone marrow toxicity in definitive chemoradiotherapy for oesophageal tumours?
door: Warren, S, et al.
Gepubliceerd in: (2016)

Correlation of 18F-fluorodeoxyglucose positron emission tomography parameters with patterns of disease progression in locally advanced pancreatic cancer after definitive chemoradiotherapy
door: Wilson, J, et al.
Gepubliceerd in: (2017)

EP-1721: Feature extraction from duodenal dose surface maps to predict toxicity in pancreatic chemoradiation
door: Witztum, A, et al.
Gepubliceerd in: (2016)

Pixel-based analysis of stomach dose-surface maps to improve toxicity predictions in gastrointestinal radiotherapy
door: Witztum, A, et al.
Gepubliceerd in: (2017)

Radiobiological determination of dose escalation and normal tissue toxicity in definitive chemoradiation therapy for esophageal cancer.
door: Warren, S, et al.
Gepubliceerd in: (2014)

Potential of Proton Therapy to Reduce Acute Hematologic Toxicity in Concurrent Chemoradiation Therapy for Esophageal Cancer
door: Warren, S, et al.
Gepubliceerd in: (2017)

Conformity analysis to demonstrate reproducibility of target volumes for Margin-Intense Stereotactic Radiotherapy for borderline-resectable pancreatic cancer.
door: Holyoake, D, et al.
Gepubliceerd in: (2016)

Investigating the toxicity and safety of radiotherapy for pancreatic cancer
door: Holyoake, D
Gepubliceerd in: (2018)

Modelling normal tissue toxicity in pancreatic chemoradiotherapy
door: Witztum, A
Gepubliceerd in: (2018)

SU-F-T-108: Texture analysis for toxicity prediction from dose surface maps.
door: Witztum, A, et al.
Gepubliceerd in: (2016)

Standard or high dose chemoradiotherapy, with or without the protease inhibitor nelfinavir, in patients with locally advanced pancreatic cancer: the phase 1/randomised phase 2 SCALOP-2 trial
door: Mukherjee, S, et al.
Gepubliceerd in: (2024)

Conformity analysis of target-volume definition for margin-directed boost in pancreatic cancer SBRT
door: Holyoake, D, et al.
Gepubliceerd in: (2016)

The effect of dose escalation on gastric toxicity when treating lower oesophageal tumours: A radiobiological investigation
door: Carrington, R, et al.
Gepubliceerd in: (2015)

Acute chemoradiotherapy toxicity in cervical cancer patients
door: Radojevic Marija Zivkovic, et al.
Gepubliceerd in: (2020-09-01)

The effect of dose escalation on gastric toxicity when treating lower oesophageal tumours: a radiobiological investigation
door: Warren, S, et al.
Gepubliceerd in: (2015)

Stomach and duodenum dose–volume constraints for locally advanced pancreatic cancer patients treated in 15 fractions in combination with chemotherapy
door: Sara Broggi, et al.
Gepubliceerd in: (2023-01-01)

ARCII: Nelfinavir, a hypoxia-modifying agent, in combination with chemoradiotherapy (CRT) in locally-advanced pancreatic cancer (LAPC)–mechanism and clinical outcomes
door: Wilson, J, et al.
Gepubliceerd in: (2017)

The impact of bone marrow irradiation dose on acute haematologic toxicity in cervical cancer patients treated with concurrent chemoradiotherapy
door: Min Chen, et al.
Gepubliceerd in: (2023-04-01)

Inflammatory Parameters as Available Prognostic Factors for Pancreatic Cancer after Chemoradiotherapy
door: Chang Min Cho
Gepubliceerd in: (2018-05-01)

A comparison of dose-volume constraints derived using peak and longitudinal definitions of late rectal toxicity.
door: Gulliford, S, et al.
Gepubliceerd in: (2010)

Dose-volume parameters predict radiation pneumonitis after induction chemoradiotherapy followed by surgery for non-small cell lung cancer: a retrospective analysis
door: Kuniaki Katsui, et al.
Gepubliceerd in: (2019-11-01)

ACUTE AND LATE TOXICITY WITH CHEMORADIOTHERAPY FOR OROPHARYNGEAL CANCER DEPENDING ON THE FRACTIONATION OPTION
door: Parkhomenko L. B.
Gepubliceerd in: (2018-12-01)

Low skeletal muscle mass is predictive of dose-limiting toxicities in head and neck cancer patients undergoing low-dose weekly cisplatin chemoradiotherapy.
door: Jan-Niklas Becker, et al.
Gepubliceerd in: (2023-01-01)

ANALYSIS OF HEMATOLOGIC, HEPATIC AND PANCREATIC TOXICITY DURING NEOADJUVANT CHEMORADIOTHERAPY IN PATIENTS WITH LOCALLY ADVANCED GASTRIC CANCER
door: V. Yu. Skoropad, et al.
Gepubliceerd in: (2018-07-01)

Improper lung volume-dose parameters are risk factors for acute fatal radiation pneumonitis among esophageal cancer patients receiving chemoradiotherapy: a case-control study
door: Ruinuo Jia, et al.
Gepubliceerd in: (2025-01-01)

SU-D-BRA-06: Duodenal interfraction motion with abdominal compression.
door: Witztum, A, et al.
Gepubliceerd in: (2016)

Radiation pneumonitis after definitive concurrent chemoradiotherapy with cisplatin/docetaxel for non‐small cell lung cancer: Analysis of dose‐volume parameters
door: Kuniaki Katsui, et al.
Gepubliceerd in: (2020-07-01)

Primary diffuse large b-cell lymphoma of the stomach presenting as acute pancreatitis
door: Sara Ghani, et al.
Gepubliceerd in: (2020-06-01)

Dose-escalated radiotherapy for unresectable or locally recurrent pancreatic cancer: Dose volume analysis, toxicity and outcome of 28 consecutive patients.
door: Sebastian Zschaeck, et al.
Gepubliceerd in: (2017-01-01)

Risk factor of pneumonitis on dose-volume relationship for chemoradiotherapy with durvalumab: Multi-institutional research in Japan
door: Yoshiko Oshiro, et al.
Gepubliceerd in: (2021-07-01)

EP-1720: Impact of contouring variability on tumour control and normal tissue toxicity in liver SBRT
door: Robinson, M, et al.
Gepubliceerd in: (2016)

The relationship between the radiation dose of pelvic-bone marrow and lymphocytic toxicity in concurrent chemoradiotherapy for cervical cancer
door: Bao-Zhong Zhang, et al.
Gepubliceerd in: (2023-01-01)

ECTOPIC PANCREATIC TISSUE IN THE STOMACH: CASE REPORT
door: Dejan Lukic, et al.
Gepubliceerd in: (2017-04-01)

Postoperative chemoradiotherapy combined with epirubicin-based triplet chemotherapy for locally advanced adenocarcinoma of the stomach or gastroesophageal junction.
door: Guichao Li, et al.
Gepubliceerd in: (2013-01-01)

Evaluating the Predictive Value of the Dose-volume Parameters and Vascular Endothelial Growth Factor Expression on Rectal Toxicity in Prostate Cancer Patients
door: Marziyeh Mirzaeiyan, et al.
Gepubliceerd in: (2024-12-01)